相关实验视频
Updated: Sep 10, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.8K
超越增长:基于人工智能临床试验的全球不平衡的注册分析
1Department of Oriental Neuropsychiatry, Dong-Eui University College of Korean Medicine, 52-57, Yangjeong-ro, Busanjin-gu, Busan 47227, Republic of Korea.
Healthcare (Basel, Switzerland)
|August 28, 2025
概括
人工智能 (AI) 临床试验正在快速增长,但主要集中在中国. 国际合作的低水平阻碍了全球卫生公平性和人工智能技术的普遍性.
科学领域:
- 临床研究
- 人工智能
- 全球健康
背景情况:
- 人工智能 (AI) 在临床研究中的整合正在加速.
- 对全球人工智能临床试验的全面分析是有限的.
- 这项研究提供了人工智能临床试验的第一个系统性描述.
研究的目的:
- 绘制AI临床试验的全球趋势.
- 确定地理和主题集中模式.
- 分析人工智能研究的国际合作结构.
主要方法:
- 在世界卫生组织 (WHO) 国际临床试验注册平台 (ICTRP) 进行了搜索.
- 在62个国家选和分析了596项人工智能临床试验.
- 使用描述性统计数据和网络分析以了解时间,地理和协作模式.
主要成果:
- 自2020年以来,人工智能临床试验的注册量呈指数级增长.
- 观察到极端的地理集中,其中中国领先 (35.6%),其次是美国 (8.5%).
- 研究重点是胃肠道学 (22.8%) 和瘤学 (20.1%),主要应用是诊断支持 (45.6%). 国际合作率较低 (8.7%).
结论:
- 全球人工智能临床试验领域呈现出快速但不平衡的增长.
- 地理集中和极少的国际合作威胁着全球健康公平.
- 迫切需要具有包容性,透明性和协作性的研究模式, 以确保人工智能带来的公平利益.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Bias in Epidemiological Studies
671
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
671
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174

